Opinion

The impact of Covid-19 will be felt across the global IP market

The race to patent a treatment for coronavirus in China is heating up, but its spread could be the story that affects every other story in tech this year

15 February 2020

Iancu makes US concerns about possible Chinese WIPO leadership clear

USPTO head tells Washington DC event that the next head of the organisation must come from a country that “respects intellectual property rights”

06 February 2020

We need better thinking on US pharma patent reforms

As the presidential race heats up - and with even self-styled Democrat centrist Michael Bloomberg now promising radical regime change - life sciences IP professionals must interject some sanity into the debate

01 February 2020

The EU should not contemplate abandoning the Unified Patent Court system

Ratification delay in Germany and the spectre of UK non-participation mean many believe the project will quietly be dropped - but to do so would be a serious mistake

11 January 2020

Even if you forget about 101 reform, don’t forget about DC

The prospects of legislation on patent eligibility may have diminished but the significance of IP policy discussions is only getting greater

14 December 2019

IoT patent owners still hold the future in their own hands – but the clock is ticking

A successful IAM conference in Munich illustrated the IP complexities that surround the platform, but licensors must think creatively - and quickly - about how to seize opportunities before others do it for them

30 November 2019

Patents are politics, as an eagerly awaited UK Supreme Court FRAND licensing ruling may soon show

A judgment that upholds the Unwired Planet and Conversant decisions could well leave British Prime Minister Boris Johnson in a difficult position

16 November 2019

The patent dodgers trolling the IP landscape

IPCom is one of Europe’s oldest NPEs – and usually one of its most reticent. Not anymore, though. In this opinion piece, managing director Pio Suh explains why he believes firms such as his have a key role to play in FRAND licensing

09 November 2019

UK general election could result in a paradigm shift on pharma IP

The Labour Party – the main opposition to Boris Johnson’s Conservatives – recently set out a radical plan to change the patent regime for life sciences innovators

02 November 2019

Unlock unlimited access to all IAM content